RMC-9805 / DARAXON portfolio
Zoldonrasib API
RMC-9805 active pharmaceutical ingredient for KRAS G12D research and pharmaceutical development. U.S. FDA DMF 44304.
Product overview
Active pharmaceutical ingredient
Zoldonrasib, development code RMC-9805, is described by its developer as a RAS(ON) G12D-selective inhibitor. Daraxon offers the API for professional development programs, with specifications and documentation scoped to the intended use.
Revolution Medicines · Zoldonrasib / RMC-9805↗- Product
- Zoldonrasib API
- Development code
- RMC-9805
- Material format
- Active pharmaceutical ingredient
- Research context
- RAS(ON) G12D-selective inhibitor
- U.S. FDA DMF
- 44304 · Type II
- Submission date
- 2026-06-08
- Status in the 2026 Q2 list
- A — Active
- FDA-listed holder
- SHANGHAI DA'AN XIN BIOMEDICAL CO LTD
Traceable filing record
FDA DMF 44304
Checked against the FDA 2026 Q2 DMF list. This is the only record under this product name in that quarterly list. A DMF filing is not FDA drug approval.
Technical documentation
Define the package for your program.
- Batch Certificate of Analysis and agreed product specification
- Identity and chromatographic records within the agreed documentation package
- DMF reference and Letter of Authorization requirements
Product inquiry
Talk to the Daraxon team.
Include intended use, quantity, destination and documentation requirements.